Trial Outcomes & Findings for mHealth Intervention Supporting HIV Treatment Adherence and Retention (NCT NCT01951092)
NCT ID: NCT01951092
Last Updated: 2016-04-22
Results Overview
A qualitative interview is completed at the end of the 6 month intervention where participants are queried on aspects of the texting intervention including: frequency of messaging, content of messaging, comfort with confidentiality with messaging, interactions between clinic staff as a result of messaging, and ideas on how to incorporate messaging clinic-wide.
COMPLETED
NA
32 participants
6 months
2016-04-22
Participant Flow
Patients at the Immunology Center in Providence RI who were either 1) newly diagnosed, 2) returning to care after a gap, 3) or with difficulties with adherence to care were eligible for enrollment in this pilot study. Participants were recruited from January 2013 through July 2013 and followed for 6 months.
Participant milestones
| Measure |
Single Arm Intervention Study
All subjects receive text messages for: 1) medication reminders; 2) appointment reminders; 3) a text message addressing barriers (e.g., reminders to attend AA meetings). Each subject will undergo baseline assessments, choose personalized messages at that time. Subsequently monthly phone calls with study coordinator regarding frequency/changing messages, and then month 3 assessment, and month 6 (final assessment) with option for qualitative interview.
Text messaging
|
|---|---|
|
Overall Study
STARTED
|
32
|
|
Overall Study
COMPLETED
|
20
|
|
Overall Study
NOT COMPLETED
|
12
|
Reasons for withdrawal
| Measure |
Single Arm Intervention Study
All subjects receive text messages for: 1) medication reminders; 2) appointment reminders; 3) a text message addressing barriers (e.g., reminders to attend AA meetings). Each subject will undergo baseline assessments, choose personalized messages at that time. Subsequently monthly phone calls with study coordinator regarding frequency/changing messages, and then month 3 assessment, and month 6 (final assessment) with option for qualitative interview.
Text messaging
|
|---|---|
|
Overall Study
Lost to Follow-up
|
10
|
|
Overall Study
Incarceration
|
1
|
|
Overall Study
Transfer of Care
|
1
|
Baseline Characteristics
mHealth Intervention Supporting HIV Treatment Adherence and Retention
Baseline characteristics by cohort
| Measure |
Single Arm Intervention Study
n=32 Participants
All subjects receive text messages for: 1) medication reminders; 2) appointment reminders; 3) a text message addressing barriers (e.g., reminders to attend AA meetings). Each subject will undergo baseline assessments, choose personalized messages at that time. Subsequently monthly phone calls with study coordinator regarding frequency/changing messages, and then month 3 assessment, and month 6 (final assessment) with option for qualitative interview.
|
|---|---|
|
Age, Continuous
|
36 years
n=99 Participants
|
|
Sex: Female, Male
Female
|
10 Participants
n=99 Participants
|
|
Sex: Female, Male
Male
|
22 Participants
n=99 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Black or African American
|
7 Participants
n=99 Participants
|
|
Race (NIH/OMB)
White
|
20 Participants
n=99 Participants
|
|
Race (NIH/OMB)
More than one race
|
2 Participants
n=99 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=99 Participants
|
|
Region of Enrollment
United States
|
32 participants
n=99 Participants
|
|
Participants with HIV PVL <200 copies/mL
|
18 participants
n=99 Participants
|
PRIMARY outcome
Timeframe: 6 monthsPopulation: All 20 participants who completed the study at 6 months participated in interviews and reported that the texting intervention was feasible and acceptable.
A qualitative interview is completed at the end of the 6 month intervention where participants are queried on aspects of the texting intervention including: frequency of messaging, content of messaging, comfort with confidentiality with messaging, interactions between clinic staff as a result of messaging, and ideas on how to incorporate messaging clinic-wide.
Outcome measures
| Measure |
Single Arm Intervention Study
n=20 Participants
All subjects receive text messages for: 1) medication reminders; 2) appointment reminders; 3) a text message addressing barriers (e.g., reminders to attend AA meetings). Each subject will undergo baseline assessments, choose personalized messages at that time. Subsequently monthly phone calls with study coordinator regarding frequency/changing messages, and then month 3 assessment, and month 6 (final assessment) with option for qualitative interview.
|
|---|---|
|
Number of Particpatns Who Considered the Intervention Feasible and Acceptable
|
20 participants
|
SECONDARY outcome
Timeframe: 6 monthsExploratory end point of PVL \<200 copies at the end of the study
Outcome measures
| Measure |
Single Arm Intervention Study
n=32 Participants
All subjects receive text messages for: 1) medication reminders; 2) appointment reminders; 3) a text message addressing barriers (e.g., reminders to attend AA meetings). Each subject will undergo baseline assessments, choose personalized messages at that time. Subsequently monthly phone calls with study coordinator regarding frequency/changing messages, and then month 3 assessment, and month 6 (final assessment) with option for qualitative interview.
|
|---|---|
|
Efficacy
|
32 participants
|
Adverse Events
Single Arm Intervention Study
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Aadia Rana, MD
Alpert Medical School of Brown University/The Miriam Hospital
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place